Assessment of erectile dysfunction in diabetic patients

被引:21
作者
Hamdan, Farqad B. [1 ]
Al-Matubsi, Hisham Y. [2 ]
机构
[1] Al Zaytoonah Private Univ, Fac Pharm, Amman, Jordan
[2] Private Jordanian Univ, Appl Sci Univ, Fac Pharm, Amman 11931, Jordan
来源
INTERNATIONAL JOURNAL OF ANDROLOGY | 2009年 / 32卷 / 02期
关键词
diabetes mellitus; erectile dysfunction; hormones; neuropathy; neurophysiological tests; oxidative stress; Valsalva ratio; BULBOCAVERNOSUS-REFLEX LATENCIES; OXIDATIVE STRESS; GLYCEMIC CONTROL; ENDOTHELIAL DYSFUNCTION; SEXUAL FUNCTION; NITRIC-OXIDE; NEUROPATHY; MELLITUS; MEN; IMPOTENCE;
D O I
10.1111/j.1365-2605.2008.00873.x
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
Erectile dysfunction (ED) aetiology is multifactorial, including endocrine, neurological, vascular, systemic disease, local penile disorders, nutrition, psychogenic factors, and drug-related. This study was performed to compare the relevant comprehensive biochemical parameters as well as the clinical characteristics in diabetic ED and healthy control subjects and to assess the occurrence of penile neuropathy in diabetic patients and thus the relationship between ED and diabetes. A total of 56 patients accepted to undergo assessment for penile vasculature using intracavernosal injection and colour Doppler ultrasonography. Of the 56 diabetic patients, 38 patients were found with normal blood flow and thus they were considered as the diabetic-ED group, whereas, ED diabetic patients with an arteriogenic component were excluded. These patients with an age range between 17 and 58 years, complaining of ED, with duration of diabetic illness ranging from 2 to 15 years. The Control group comprised of 30 healthy subject aged between 19 and 55 years. Peripheral venous levels of testosterone, prolactin, follicle stimulating hormone (FSH), luteinizing hormone (LH), thyroid stimulating hormone (TSH), malondialdehyde and glycosylated haemoglobin (HbA(1)c) were obtained in all subjects. Valsalva manoeuvre and neurophysiological tests were also determined. Testosterone, prolactine, FSH, LH, and TSH hormones of the diabetic patients were not significantly different from those of the control group. Diabetic patients with ED have higher HbA(1)c and oxidative stress levels while the R-R ratio was significantly decreased. Bulbocavernosus reflex latency was significantly prolonged, whereas its amplitude, the conduction velocity and amplitude of dorsal nerve of penis were significantly reduced in the diabetic patients. We concluded that although ED is a multifactorial disorder, yet, the present study revealed that in ED patients without arteriogenic ED a neurogenic component is present. Furthermore, the complex effect of the Valsalva manoeuvre on cardiovascular function is the basis of its usefulness as a measure of autonomic function. Thus, it can be of value in the diagnosis of ED although these hypotheses require follow-up in a large study cohort.
引用
收藏
页码:176 / 185
页数:10
相关论文
共 62 条
[1]  
Alexopoulou O, 2001, DIABETES METAB, V27, P329
[2]  
AMARENCO G, 1997, REPORT 186 CASES NEU, V27, P51
[3]   PHYSIOLOGY OF PENILE ERECTION [J].
ANDERSSON, KE ;
WAGNER, G .
PHYSIOLOGICAL REVIEWS, 1995, 75 (01) :191-236
[4]   The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM) [J].
Azad, N ;
Emanuele, NV ;
Abraira, C ;
Henderson, WG ;
Colwell, J ;
Levin, SR ;
Nuttall, FQ ;
Comstock, JP ;
Sawin, CT ;
Silbert, C ;
Rubino, FA .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 1999, 13 (5-6) :307-313
[5]   ERECTILE DYSFUNCTION IN DIABETIC MEN - THE NEUROLOGICAL FACTOR REVISITED [J].
BEMELMANS, BLH ;
MEULEMAN, EJH ;
DOESBURG, WH ;
NOTERMANS, SLH ;
DEBRUYNE, FMJ .
JOURNAL OF UROLOGY, 1994, 151 (04) :884-889
[6]   Laboratory evaluations of erectile dysfunction: An evidence based approach [J].
Bodie, J ;
Lewis, J ;
Schow, D ;
Monga, M .
JOURNAL OF UROLOGY, 2003, 169 (06) :2262-2264
[7]   Urologic complications of diabetes [J].
Brown, JS ;
Wessells, H ;
Chancellor, MB ;
Howards, SS ;
Stamm, WE ;
Stapleton, AE ;
Steers, WD ;
Van Den Eeden, SK ;
McVary, KT .
DIABETES CARE, 2005, 28 (01) :177-185
[8]   GLYCATION PRODUCTS AND THE PATHOGENESIS OF DIABETIC COMPLICATIONS [J].
BROWNLEE, M .
DIABETES CARE, 1992, 15 (12) :1835-1843
[9]  
Buege J A, 1978, Methods Enzymol, V52, P302
[10]  
Burnett AL, 1998, GERIATRICS, V53, P34